Filter
6140
Filtered Results: 6140
Text search:
exposure
Featured
Recommendations
580
New Publications
1454
Language
Document type
No document type
3318
Studies & Reports
1029
Guidelines
906
Manuals
326
Strategic & Response Plan
191
Fact sheets
177
Training Material
81
Situation Updates
48
Infographics
34
Resource Platforms
16
Brochures
6
Online Courses
4
Dashboards/Maps
2
Videos
2
Countries / Regions
Global
277
India
262
Kenya
176
South Africa
147
Nigeria
118
Sierra Leone
117
Western and Central Europe
116
Liberia
109
Nepal
107
Ethiopia
104
Africa
97
Uganda
84
Tanzania
80
Bangladesh
78
Myanmar / Burma
77
Rwanda
74
Syria
74
Zambia
74
Latin America and the Carribbean
73
Malawi
72
Ghana
71
Ukraine
62
Philippines
56
Namibia
46
South–East Asia Region
43
West and Central Africa
41
Zimbabwe
38
Asia
38
Congo, Democratic Republic of
38
Eastern Europe
38
Indonesia
36
Lesotho
35
Brazil
35
East and Southern Africa
34
South Sudan
34
Mozambique
33
Cambodia
33
Guinea
31
Middle East and North Africa
29
Russia
28
Senegal
25
USA
25
Germany
23
Burkina Faso
22
Botswana
21
Eastern Europe and Central Asia
20
Haiti
19
Yemen
19
Pakistan
18
Western Pacific Region
17
Eswatini/ Swaziland
16
Afghanistan
15
Venezuela
15
Lebanon
15
Vietnam
13
Colombia
12
Thailand
12
Mali
12
Cameroon
11
Angola
10
China
9
Laos
9
Peru
9
Sudan
9
Somalia
9
Jordan
8
Paraguay
8
United Kingdom
8
Côte d’Ivoire / Ivory Coast
8
Madagascar
8
Tajikistan
7
Argentina
7
Moldova
7
Palestine
7
Sri Lanka
6
Georgia
6
Central African Republic
6
Chile
5
Niger
5
Burundi
5
Mexico
4
Iran
4
Albania
4
Malaysia
4
Guinea-Bissau
4
Ireland
4
Spain
4
Southern Africa
4
Egypt
4
Libya
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Canada
3
Singapore
3
Armenia
3
North America
3
Portugal
3
Bolivia
3
Honduras
3
Bhutan
3
Ecuador
3
Guatemala
3
El Salvador
2
Turkey
2
Gambia
2
Kazakhstan
2
Fiji
2
Kyrgyzstan
2
Morocco
2
Dominican Republic
2
Saudi Arabia
2
France
2
Mauritius
2
Papua New Guinea
2
Chad
2
Serbia
1
Australia
1
Estonia
1
Congo-Brazzaville
1
Qatar
1
Italy
1
Lithuania
1
Gabon
1
Uruguay
1
Japan
1
Belgium
1
Tunisia
1
South Korea
1
Azerbaijan
1
Belarus
1
Israel
1
Latvia
1
Nicaragua
1
Djibouti
1
Romania
1
Greece
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2025
Clinical Guidelines
490
Public Health
382
Women & Child Health
275
Key Resources
274
Capacity Building
82
Pharmacy & Technologies
74
Toolboxes
COVID-19
659
HIV
628
Mental Health
473
Planetary Health
319
TB
300
Ebola
233
Rapid Response
208
NCDs
168
Conflict
168
NTDs
159
Caregiver
155
AMR
138
Disability
113
Refugee
100
Pharmacy
96
Natural Hazards
95
Global Health Education
94
Specific Hazards
92
Zika
68
Polio
31
Cholera
27
Health Financing Toolbox
25
Social Ethics
12
Typhoon
2
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
As a central component of the UNHCR Strategic Directions 2022-2026, UNHCR has identified eight focus areas for renewed attention and accelerated action, including Climate Action. This Focus Area Strategic Plan for Climate Action sets out a global roadmap for prioritized action, providing further cla...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the trend in CVD incidence, mortality, and mortality-to-...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public health issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwid...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
The 2019-2023 Strategy for UNU-IIGH, developed in
2018, built on UNU-IIGH’s strategic advantage and
position vis-à-vis the UN and global health ecosystem.
The Strategy set a goal to advance evidencebased policy on key issues related to sustainable
development and health and shifted the Instit...
A major problem facing the world is how to build peace following the ravages of increasingly protracted armed conflict. Armed conflicts leave behind shattered, divided societies that are at risk of repeating cycles of violence, and therefore need concerted peacebuilding efforts. Conflicts also take ...
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
